Definitive Contract 75N93018C00016
Award Date
7/26/18
Potential Completion Date
5/31/21
Potential Value
$599K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Dexorgen Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20879, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. The $15,100 firm fixed-price purchase order contract is for Codex Biosolutions to provide research and development services, including generating custom cell lines and supplying pseudovirus particles and stable cell lines expressing SARS-CoV-2 variants to...
This $18,000 firm fixed price purchase order was awarded by the National Institutes of Health's National Institute on Drug Abuse to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. Codex Biosolutions provides cell-based assay products and services to support research and development activities for government agencies, pharmaceutical companies, and other institutes. Under this contract, Codex is tasked with delivering specialized cell lines,...
This is a $29,400 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Dexorgen Inc., doing business as Codex Biosolutions Inc. Codex Biosolutions is a minority-owned, small disadvantaged business that specializes in advanced biotechnological research, particularly in cell line development, genetic engineering, and translational science support. The contract,...
Codex Biosolutions Inc. has been awarded a firm fixed price purchase order valued at $22,620 by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health within the Department of Health and Human Services, to deliver an EXPI293 stable cell line overexpressing HTLV envelope protein in support of NIAID's efforts to develop treatments and preventions for infectious diseases. The research and development will be conducted by Codex...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $25,000 firm fixed price purchase order to Codex Biosolutions Inc., located in Gaithersburg, Maryland. Codex Biosolutions will provide research and development services under the award, which runs from September 1, 2023 through August 31, 2024. As the prime contractor, Codex Biosolutions will leverage its expertise to support the National Center for...
Codex Biosolutions Inc. Research and Development Division, doing business as Codex Biosolutions Inc., has been awarded a $18,400 firm fixed-price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide cell line generation services. The contract has a period of performance of September 1, 2023 through August 31, 2024 and will be performed in Gaithersburg, Maryland. No set-aside designation or subcontractors were indicated. The award...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $25,770.00 firm-fixed price purchase order to Dexorgen Inc., dba Codex Biosolutions Inc., a minority-owned small business, to provide HTLV envelope protein production services. The purpose is to construct stable cell lines to increase yields of HTLV-1 envelope proteins for structural analysis and research conducted by the Vaccine Research Center (VRC). This sole-source...
This contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. The $18,060 firm fixed-price purchase order is for screening services to identify small molecule antagonists of the GPR17 receptor, which is involved in various diseases. Codex Biosolutions specializes in cell-based assays and has received numerous NIH contracts for research and...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded Codex Biosolutions Inc., a small disadvantaged and minority-owned business, a firm fixed-price Small Business Innovation Research (SBIR) Phase I contract for the "DEVELOPMENT OF NOVEL PDE4B INHIBITORS TO TREAT ALCOHOL USE DISORDER" worth $224,656.00. As the prime contractor, Codex Biosolutions will provide specialized bioengineering, genomic...
This is a $599,999 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Parabon NanoLabs, Inc., a small business. The objective of the contract is to develop a DNA-based HIV vaccine that will stimulate production of broadly neutralizing antibodies against the HIV-1 envelope protein trimer antigen. This is a Phase I Small Business Innovation Research (SBIR) contract under the...